Internal Medicine, Hematology & Oncology · Beachwood, OH
NPI
1104960525
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
26900 Cedar Rd, 330-S
Beachwood, OH, 44122
Phone (216) 839-2990
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
676 services
Medicare patients, 2024
218
Average age 75
Drug cost, 2024
$4.7M
1,236 prescriptions
Company payments, 2025
$54K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Prateek Mendiratta was code 99214 (office e&m - established), 412 times for 162 patients. In total Prateek Mendiratta billed 676 services in 16 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 412 | 162 | $66.73 | $27K |
| 99443 Telephone Services | Facility | 76 | 55 | $66.17 | $5,029 |
| 99232 Hospital E&M - Subsequent | Facility | 60 | 20 | $59.71 | $3,583 |
| 99442 Telephone Services | Facility | 39 | 30 | $45.81 | $1,787 |
| 99204 Office E&M - New | Facility | 30 | 30 | $90.95 | $2,728 |
| 99205 Office E&M - New | Facility | 15 | 15 | $111.17 | $1,668 |
| 99215 Office E&M - Established | Facility | 14 | 13 | $77.99 | $1,092 |
| 99238 Hospital Discharge Management | Facility | 13 | 13 | $61.13 | $795 |
By year: 2022 $42K for 470 services; 2023 $35K for 483 services; 2024 $45K for 676 services.
Medicare prescription drug claims, 2024
In 2024, the drug Prateek Mendiratta prescribed most often to Medicare patients was Prednisone, with 270 prescriptions and refills. In total Prateek Mendiratta wrote 1,236 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 270 | 312 | 61 | $904 |
| Abiraterone Acetate Generic | 199 | 201 | 37 | $319K |
| Xtandi Enzalutamide | 88 | 88 | 15 | $931K |
| Orgovyx Relugolix | 83 | 83 | 20 | $224K |
| Erleada Apalutamide | 71 | 82 | 14 | $1.0M |
| Gabapentin Generic | 43 | 49 | 12 | $218 |
| Prochlorperazine Maleate Generic | 37 | 37 | 28 | $387 |
| Potassium Chloride Generic | 36 | 37 | 15 | $254 |
| Nubeqa Darolutamide | 33 | 33 | Under 11 | $453K |
| Ondansetron Hcl Generic | 31 | 31 | 25 | $651 |
| Tamsulosin Hcl Generic | 31 | 59 | 13 | $114 |
| Bicalutamide Generic | 29 | 39 | 21 | $790 |
| Levothyroxine Sodium Generic | 22 | 28 | Under 11 | $72.06 |
| Fotivda Tivozanib Hcl | 21 | 21 | Under 11 | $632K |
| Cabometyx Cabozantinib S-Malate | 19 | 19 | Under 11 | $483K |
Brand drugs: 368 claims; generic drugs: 868 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Prateek Mendiratta $54K ($54K in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $29K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 23 | $29K |
| Pfizer Inc. PFE | 8 | $19K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $2,881 |
| Astellas Pharma US Inc 4503.T | 3 | $2,149 |
| Janssen Biotech, Inc. JNJ | 5 | $1,318 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $134 |
| Abbvie Inc. ABBV | 3 | $85.71 |
| Merck Sharp & Dohme LLC MRK | 4 | $77.16 |
| Genzyme Corporation SNY | 2 | $39.7 |
| Gilead Sciences, Inc. GILD | 1 | $22.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.